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Background
Breast cancer is a disease caused by uncontrolled cell
division of epithelial cells in the ducts or the lobules of
the breast. The ducts and lobules are enclosed by a
basement membrane, and during progression of the dis-
ease the invading cells will breach the membrane and
invade adjacent tissue. A tumor that is still enclosed in
the basement membrane is called a carcinoma in situ,
while a tumor that has breached the basement mem-
brane is called an invasive carcinoma. DNA methylation
is a DNA modification where methyl groups are added
to CpG dinucleotides and thought to regulate gene
expression through blocking of transcription factor
binding or through chromatin remodeling. The aim of
the study was to determine what genes get differentially
methylated when the cancer progresses from a less to a
more aggressive carcinoma. In addition, by applying
integrated analysis of other molecular data such as gene
expression and copy number, we could investigate how
more elaborate biological processes change during pro-
gression. Being able to determine the processes that
take place during progression of breast cancer may give
valuable insight into cancer biology, as well as identifica-
tion of early markers of disease.
Materials and methods
Methylation status of 239 tumors and 46 healthy tissue
controls were determined by lllumina Infinium 450K
methylation array, interrogating about 480 000 CpGs
distributed in promoters, gene bodies, 3’UTRs and inter-
genic regions. Gene expression, miRNA expression,
array CGH and clinical parameters are available for a
subset of samples. The samples were collected at hospi-
tals in Oslo/Akershus, Norway, and all patients have
given informed consent and the projects are approved
by the local ethical committee.
Results
Results that will be presented include differentially
methylated genes between healthy breast tissue with
varying mammographic density, differentially methylated
genes between healthy tissue and carcinoma in situ and
differentially methylated genes between carcinoma in
situ and early stage invasive carcinoma. Methylation
level of CpGs in many genes showed differential methy-
lation when comparing in situ carcinoma and invasive
carcinoma. The top hits include CTNNA1, FAIM2,
MCAM, PDZK1, PLAT, PPP2R1B and PSG3 - genes that
are involved in cell differentiation, growth and adhesion.
Also investigated was the association between DNA
methylation and gene expression, with focus on CpG
position relative to transcription start site. Preliminary
results indicate that almost a third of significant hits
show a positive correlation between methylation and
expression. CpGs with positive correlation to gene
expression were most often found in gene bodies and
3’UTRs.These findings challenge the traditional view
that DNA methylation can only inhibit gene expression.
Conclusions
We observe changes in DNA methylation patterns
between tissues with varying stage of progression in breast
cancer and we report both positive and negative correla-
tion between DNA methylation and gene expression.
1Department of Genetics, Institute for Cancer Research, Oslo University
Hospital Radiumhospitalet, Oslo, Norway
Full list of author information is available at the end of the article
Fleischer et al. Epigenetics & Chromatin 2013, 6(Suppl 1):P18
http://www.epigeneticsandchromatin.com/content/6/S1/P18
© 2013 Fleischer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Author details
1Department of Genetics, Institute for Cancer Research, Oslo University
Hospital Radiumhospitalet, Oslo, Norway. 2The K.G. Jebsen Center for Breast
Cancer Research, Institute for Clinical Medicine, Faculty of Medicine,
University of Oslo, Norway. 3Institute for Clinical Epidemiology and Molecular
Biology (EpiGen), Faculty of Medicine, University of Oslo, Norway.
4Laboratory for Epigenetics, Centre National de Génotypage, CEA - Institut
de Génomigue, 91000 Evry France.
Published: 18 March 2013
doi:10.1186/1756-8935-6-S1-P18
Cite this article as: Fleischer et al.: DNA methylation and gene
expression patterns in breast cancer progression from in situ carcinoma
to invasive carcinoma. Epigenetics & Chromatin 2013 6(Suppl 1):P18.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Fleischer et al. Epigenetics & Chromatin 2013, 6(Suppl 1):P18
http://www.epigeneticsandchromatin.com/content/6/S1/P18
Page 2 of 2
